Kimia Biosciences Profile
Key Indicators
- Authorised Capital ₹ 16.39 Cr
as on 16-11-2024
- Paid Up Capital ₹ 4.73 Cr
as on 16-11-2024
- Company Age 31 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 44.10 Cr
as on 16-11-2024
- Satisfied Charges ₹ 68.78 Cr
as on 16-11-2024
- Revenue 3.10%
(FY 2023)
- Profit -152.56%
(FY 2023)
- Ebitda -888.07%
(FY 2023)
- Net Worth -63.31%
(FY 2023)
- Total Assets 10.80%
(FY 2023)
About Kimia Biosciences
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 530313.
The Corporate was formerly known as Dolphin Organics Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 16.39 Cr and a paid-up capital of Rs 4.73 Cr.
The company currently has active open charges totaling ₹44.10 Cr. The company has closed loans amounting to ₹68.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Kimia Biosciences Limited India are Rakesh Chetani as CFO and Sameer Goel as Ceo. Vipul Goel, Sameer Goel, Jagdeep Dhawan, and One other member serve as directors at the Company.
- CIN/LLPIN
L24239HR1993PLC032120
- Company No.
032120
- Stock Symbol
BSE : 530313
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Sep 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Kimia Biosciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sameer Goel  | Managing Director | 29-Mar-2016 | Current |
| Rakesh Chetani | CFO | 07-Sep-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vipul Goel | Director | 21-Dec-2018 | Current |
| Jagdeep Dhawan | Director | 29-Mar-2016 | Current |
| Richa Gupta | Director | 15-Apr-2016 | Current |
Financial Performance and Corporate Structure Insights of Kimia Biosciences.
Kimia Biosciences Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.1% increase. The company also saw a substantial fall in profitability, with a 152.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 63.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kimia Biosciences?
In 2023, Kimia Biosciences had a promoter holding of 74.94% and a public holding of 25.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Zeneses Biosciences Private LimitedActive 21 years 18 days
Vipul Goel and Sameer Goel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 Aug 2022 | ₹9.60 M | Open |
Hdfc Bank Limited Creation Date: 24 Mar 2022 | ₹2.10 M | Open |
Hdfc Bank Limited Creation Date: 05 Feb 2021 | ₹42.69 Cr | Open |
How Many Employees Work at Kimia Biosciences?
Kimia Biosciences has a workforce of 229 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kimia Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kimia Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
